keyword
https://read.qxmd.com/read/38385397/frequency-of-complications-after-kidney-transplant-in-the-early-postoperative-period
#21
JOURNAL ARTICLE
Farhod Khadjibaev, Pulat Sultanov, Dilshod Ergashev, Ruslan Sadikov, Jur'at Djuraev, Nurbek Iskhakov, Azizbek Ismatov
OBJECTIVES: Complications after kidney transplant can be divided into surgical and nonsurgical. Our study investigated the incidence of postoperative complications and types of complications in a single center. MATERIALS AND METHODS: We retrospectively analyzed the occurrence of postoperative complications in 220 patients who underwent kidney transplantation at the Republican Scientific Center for Emergency Medical Care (Tashkent, Republic of Uzbekistan) from January 2019 to October 2022...
January 2024: Experimental and Clinical Transplantation
https://read.qxmd.com/read/38380175/a-gentler-approach-to-monitor-for-heart-transplant-rejection
#22
REVIEW
Jason F Goldberg, Aditya Mehta, Rupinder K Bahniwal, Sean Agbor-Enoh, Palak Shah
Despite developments in circulating biomarker and imaging technology in the assessment of cardiovascular disease, the surveillance and diagnosis of heart transplant rejection has continued to rely on histopathologic interpretation of the endomyocardial biopsy. Increasing evidence shows the utility of molecular evaluations, such as donor-specific antibodies and donor-derived cell-free DNA, as well as advanced imaging techniques, such as cardiac magnetic resonance imaging, in the assessment of rejection, resulting in the elimination of many surveillance endomyocardial biopsies...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38375637/racial-differences-in-donor-derived-cell-free-dna-and-mitochondrial-dna-after-heart-transplantation-on-behalf-of-the-graft-investigators
#23
JOURNAL ARTICLE
Palak Shah, Sean Agbor-Enoh, Seiyon Lee, Temesgen E Andargie, Shashank S Sinha, Hyesik Kong, Lawrence Henry, Woojin Park, Erick McNair, Inna Tchoukina, Keyur B Shah, Samer S Najjar, Steven Hsu, Maria E Rodrigo, Moon Kyoo Jang, Charles Marboe, Gerald J Berry, Hannah A Valantine
BACKGROUND: Black heart transplant patients are at higher risk of acute rejection (AR) and death than White patients. We hypothesized that this risk may be associated with higher levels of donor-derived cell-free DNA (dd-cfDNA) and cell-free mitochondrial DNA. METHODS: The Genomic Research Alliance for Transplantation is a multicenter, prospective, longitudinal cohort study. Sequencing was used to quantitate dd-cfDNA and polymerase chain reaction to quantitate cell-free mitochondrial DNA in plasma...
February 20, 2024: Circulation. Heart Failure
https://read.qxmd.com/read/38373559/relationship-between-donor-derived-cell-free-dna-and-tissue-based-rejection-related-transcripts-in-heart-transplantation
#24
JOURNAL ARTICLE
Dae Hyun Lee, Ahsan Usmani, Robby Wu, Tammi Wicks, Caroline Y Noh, Ryan Burke, Vani Ravichandran, Theresa Wolf-Doty, Ioana Dumitru, Guilherme H Oliveira, Peter Berman, Benjamin Mackie
INTRODUCTION: Endomyocardial biopsy (EMB)-based traditional microscopy remains the gold standard for the detection of cardiac allograft rejection, despite its limitation of inherent subjectivity leading to inter-reader variability. Alternative techniques now exist to surveil for allograft injury and classify rejection. Donor-derived cell-free DNA (dd-cfDNA) testing is now a validated blood-based assay used to surveil for allograft injury. The molecular microscope diagnostic system (MMDx) utilizes intragraft rejection-associated transcripts (RATs) to classify allograft rejection and identify injury...
February 17, 2024: Journal of Heart and Lung Transplantation
https://read.qxmd.com/read/38367601/hepatic-granulomas-following-liver-transplantation-a-retrospective-survey-and-analysis-of-possible-microbiological-etiology
#25
JOURNAL ARTICLE
Anisoara Iordache, Kurt Fuursted, Charlotte Vestrup Rift, Allan Rasmussen, Gro Linno Willemoe, Jane Preuss Hasselby
BACKGROUND: Liver granulomas have always been a diagnostic challenge for pathologists. They have been described in up to 15% of liver biopsies and can also be seen in liver allograft biopsy specimens, but there is a paucity of information regarding the prevalence and associated etiologic factors of granulomas in liver transplanted patients. The aim of this study is to shed light on the etiology of liver granulomas. METHODS: Liver biopsies from liver transplanted patients, in the period from 01...
February 9, 2024: Pathology, Research and Practice
https://read.qxmd.com/read/38358857/longitudinal-lower-airway-microbial-signatures-of-acute-cellular-rejection-in-lung-transplantation
#26
JOURNAL ARTICLE
Jake G Natalini, Kendrew K Wong, Nathaniel C Nelson, Benjamin G Wu, Darya Rudym, Melissa B Lesko, Seema Qayum, Tyler C Lewis, Adrian Wong, Stephanie H Chang, Justin C Y Chan, Travis C Geraci, Yonghua Li, Chan Wang, Huilin Li, Prerna Pamar, Joseph Schnier, Ian J Mahoney, Tahir Malik, Fares Darawshy, Imran Sulaiman, Matthias C Kugler, Rajbir Singh, Destiny E Collazo, Miao Chang, Shrey Patel, Yaa Kyeremateng, Colin McCormick, Clea R Barnett, Jun-Chieh J Tsay, Shari B Brosnahan, Shivani Singh, Harvey I Pass, Luis F Angel, Leopoldo N Segal
Rationale: Acute cellular rejection (ACR) after lung transplantation is a leading risk factor for chronic lung allograft dysfunction. Prior studies have demonstrated dynamic microbial changes occurring within the allograft and gut that influence local adaptive and innate immune responses. However, the lung microbiome's overall impact on ACR risk remains poorly understood. Objective: To evaluate whether temporal changes in microbial signatures were associated with the development of ACR. Methods: We performed cross-sectional and longitudinal analyses (joint modeling of longitudinal and time-to-event data and trajectory comparisons) of 16S rRNA gene sequencing results derived from lung transplant recipient lower airway samples collected at multiple timepoints...
February 15, 2024: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38357233/monitoring-of-plasma-circulating-donor-dna-reflects-cardiac-graft-injury-report-of-two-cases
#27
Dana Dlouha, Pavlina Huckova, Eva Rohlova, Jevgenija Vymetalova, Sarka Novakova, Jaroslav A Hubacek
The current standard for graft rejection surveillance is endomyocardial biopsy (EMB), an invasive procedure with rare but potentially serious complications. Detection of circulating donor-derived cell-free DNA (ddcfDNA) is an option for noninvasive monitoring of graft injury and rejection. A 63-year-old man and a 65-year-old woman were monitored by EMB for allograft rejection. A total of 48 single-nucleotide polymorphisms with a minor allele frequency range of 0.4-0.5 were screened to distinguish donor and recipient DNA based on homozygosity, and digital droplet PCR was used to analyze ddcfDNA concentrations...
March 2024: Biomedical Reports
https://read.qxmd.com/read/38340315/advances-in-injectable-hydrogels-for-radiation-induced-heart-disease
#28
JOURNAL ARTICLE
Lu-Yao Zhao, Xin-Yue Wang, Mei-Ling Wen, Ning-Ning Pan, Xing-Qi Yin, Mei-Wen An, Li Wang, Yang Liu, Jian-Bo Song
Radiological heart damage (RIHD) is damage caused by unavoidable irradiation of the heart during chest radiotherapy, with a long latency period and a progressively increasing proportion of delayed cardiac damage due to conventional doses of chest radiotherapy. There is a risk of inducing diseases such as acute/chronic pericarditis, myocarditis, delayed myocardial fibrosis and damage to the cardiac conduction system in humans, which can lead to myocardial infarction or even death in severe cases. This paper details the pathogenesis of RIHD and gives potential targets for treatment at the molecular and cellular level, avoiding the drawbacks of high invasiveness and immune rejection due to drug therapy, medical device implantation and heart transplantation...
February 10, 2024: Journal of Biomaterials Science. Polymer Edition
https://read.qxmd.com/read/38338013/treatment-of-equine-tarsus-long-medial-collateral-ligament-desmitis-with-allogenic-synovial-membrane-mesenchymal-stem-stromal-cells-enhanced-by-umbilical-cord-mesenchymal-stem-stromal-cell-derived-conditioned-medium-proof-of-concept
#29
JOURNAL ARTICLE
Inês Leal Reis, Bruna Lopes, Patrícia Sousa, Ana Catarina Sousa, Mariana V Branquinho, Ana Rita Caseiro, Alexandra Rêma, Inês Briote, Carla M Mendonça, Jorge Miguel Santos, Luís M Atayde, Rui D Alvites, Ana Colette Maurício
Horses are high-performance athletes prone to sportive injuries such as tendonitis and desmitis. The formation of fibrous tissue in tendon repair remains a challenge to overcome. This impels regenerative medicine to develop innovative therapies that enhance regeneration, retrieving original tissue properties. Multipotent Mesenchymal Stem/Stromal Cells (MSCs) have been successfully used to develop therapeutic products, as they secrete a variety of bioactive molecules that play a pivotal role in tissue regeneration...
January 24, 2024: Animals: An Open Access Journal From MDPI
https://read.qxmd.com/read/38336485/magnifying-endoscopy-with-narrow-band-imaging-for-graft-failure-and-disease-recurrence-in-patients-with-crohn-disease-after-intestinal-transplantation-2-case-reports
#30
JOURNAL ARTICLE
Chen-Huan Yu, Yun Chen, Chien-Chen Tsai, Tzong-Hsi Lee, Ya-Hui Tsai, Chen-Shuan Chung
Crohn disease (CD) is one of the most common causes of short bowel syndrome and intestinal failure. Intestinal transplantation (IT) is sometimes needed for patients with CD who develop intestinal failure after multiple intestinal resections resulting from CD-related complications, such as uncontrollable bleeding and penetrating diseases. However, there have been few case reports concerning the endoscopic surveillance of patients with CD after IT. In this article, we present 2 patients with CD who underwent IT because of short bowel syndrome with intestinal failure...
February 8, 2024: Transplantation Proceedings
https://read.qxmd.com/read/38334806/overcoming-the-boundaries-of-heart-warm-ischemia-in-donation-after-circulatory-death-the-padua-case
#31
JOURNAL ARTICLE
Gino Gerosa, Paolo Zanatta, Annalisa Angelini, Marny Fedrigo, Roberto Bianco, Demetrio Pittarello, Tea Lena, Alessia Pepe, Giuseppe Toscano, Fabio Zanella, Giuseppe Feltrin, Nicola Pradegan, Vincenzo Tarzia
A 45 year old male obese patient with a previous history of repaired congenital heart disease developed worsening heart failure making heart transplantation listing mandatory. Unfortunately, due to his anthropometric measures, the search for a suitable brain-dead donor was unsuccessful. For this reason, he accepted to be enrolled in the controlled donation after circulatory death (cDCD) program. According to the Italian Law regulating death declaration after cardiac arrest (no-touch period of 20 minutes-one of the longest in the world), we faced a 34 minute cardiac asystole, after which the heart was recovered through a thoraco-abdominal normothermic regional perfusion excluding the epiaortic vessels...
February 9, 2024: ASAIO Journal: a Peer-reviewed Journal of the American Society for Artificial Internal Organs
https://read.qxmd.com/read/38329123/eosinophils-restrain-humoral-alloimmunity-after-lung-transplantation
#32
JOURNAL ARTICLE
Zhongcheng Mei, May A Khalil, Yizhan Guo, Dongge Li, Anirban Banerjee, Yuriko Terada, Yuhei Yokoyama, Christina Kratzmeier, Kelly Chen, Lushen Li, Christine L Lau, Jean-Paul Courneya, Irina G Luzina, Sergei P Atamas, Andrew E Gelman, Daniel Kreisel, Elizabeth A Jacobsen, Alexander S Krupnick
While the function of many leukocytes in transplant biology has been well defined, the role of eosinophils is controversial and remains poorly explored. Conflicting data exist regarding eosinophils' role in alloimmunity. Due to their prevalence in the lung, and their defined role in other pulmonary pathologies such as asthma, we set out to explore the role of eosinophils in the long-term maintenance of the lung allograft. We noted that depletion of eosinophils results in the generation of donor-specific antibodies...
February 8, 2024: JCI Insight
https://read.qxmd.com/read/38325525/three-year-outcomes-of-de-novo-tacrolimus-extended-release-tablets-lcpt-compared-to-twice-daily-tacrolimus-in-adult-heart-transplantation
#33
JOURNAL ARTICLE
Amit Alam, Johanna S van Zyl, Raksha Patel, Aayla K Jamil, Joost Felius, Sandra A Carey, Robert L Gottlieb, Cesar Y Guerrero-Miranda, Parag Kale, Shelley A Hall, Teena Sam
BACKGROUND: Extended-release tacrolimus for prophylaxis of allograft rejection in heart transplant (HT) recipients is currently not FDA-approved. One such extended-release formulation of tacrolimus known as LCPT allows once-daily dosing and improves bioavailability compared to immediate-release (IR-) tacrolimus. We compared long-term efficacy and safety of LCPT to IR-tacrolimus applied de novo in adult OHT recipients. METHODS: 25 prospective recipients on LCPT at our center from 2017 to 2019 were matched 1:2 with historical control recipients treated with IR-tacrolimus based on age, gender, and baseline creatinine...
February 5, 2024: Transplant Immunology
https://read.qxmd.com/read/38295008/circulating-t-cell-specific-extracellular-vesicle-profiles-in-cardiac-allograft-acute-cellular-rejection
#34
JOURNAL ARTICLE
Laxminarayana Korutla, Jessica R Hoffman, Susan Rostami, Robert Hu, Varun Korutla, Caroline Markmann, Clancy Mullan, Alex Sotolongo, Andreas Habertheuer, Connie Romano, Michael Acker, Sounok Sen, Divyansh Agarwal, Arun Jayaraman, Bo Li, Michael E Davis, Ali Naji, Prashanth Vallabhajosyula
There is a critical need for biomarkers of acute cellular rejection (ACR) in organ transplantation. We hypothesized that ACR leads to changes in donor-reactive T cell small extracellular vesicle (sEV) profiles in transplant recipient circulation that match the kinetics of alloreactive T cell activation. In rodent heart transplantation, circulating T cell sEV quantities (P < .0001) and their protein and mRNA cargoes showed time-specific expression of alloreactive and regulatory markers heralding early ACR in allogeneic transplant recipients but not in syngeneic transplant recipients...
October 30, 2023: American Journal of Transplantation
https://read.qxmd.com/read/38291584/rna-sequencing-of-human-kidney-allografts-and-delineation-of-t-cell-genes-gene-sets-and-pathways-associated-with-acute-t-cell-mediated-rejection
#35
JOURNAL ARTICLE
Franco B Mueller, Hua Yang, Carol Li, Darshana M Dadhania, Jenny Z Xiang, Steven P Salvatore, Surya V Seshan, Vijay K Sharma, Manikkam Suthanthiran, Thangamani Muthukumar
BACKGROUND: Delineation of T-cell genes, gene sets, pathways, and T-cell subtypes associated with acute T cell-mediated rejection (TCMR) may improve its management. METHODS: We performed bulk RNA-sequencing of 34 kidney allograft biopsies (16 Banff TCMR and 18 no rejection [NR] biopsies) from 34 adult recipients of human kidneys. Computational analysis was performed to determine the differential intragraft expression of T-cell genes at the level of single-gene, gene set, and pathways...
January 31, 2024: Transplantation
https://read.qxmd.com/read/38291576/impact-of-acute-exacerbation-of-idiopathic-pulmonary-fibrosis-on-lung-transplant-outcomes
#36
JOURNAL ARTICLE
Krishnan Warrior, Karen Sayad, Christopher P O'Hara, Daniel F Dilling
BACKGROUND: Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) are acute, significant respiratory deteriorations in patients with IPF and can lead to increased morbidity and mortality. It remains unclear how AE-IPF impacts lung transplant (LTX) outcomes. METHODS: All adult patients who were listed for LTX between July 2005 and October 2020 at the Loyola University Medical Center with a diagnosis of IPF were included. Pretransplant characteristics and posttransplant outcomes were gathered via retrospective chart review...
January 31, 2024: Transplantation
https://read.qxmd.com/read/38283705/abo-incompatible-living-donor-liver-transplantation-in-children-a-single-centre-experience-from-india
#37
JOURNAL ARTICLE
Vipul Gautam, Vikram Kumar, Shaleen Agarwal, Subhash Gupta
BACKGROUND: In recent years, paediatric ABO incompatible (ABOi) living donor liver transplant (LT) has shown promising outcomes and can potentially eliminate organ shortage. This study aims to report paediatric ABOi LT experience, including short- and long-term outcomes. METHODS: It is a single-centre retrospective study. Out of 108 LTs, 20 were done in children. We compared the outcomes between ABOi (n = 20) and non-ABOi (n = 220) paediatric living donor liver transplantation (LDLT) performed during the study period...
2024: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/38279485/galectin-9-contributes-to-the-survival-of-fully-allogeneic-skin-grafts-by-modulating-effector-t-cells-and-tregs-imbalance
#38
JOURNAL ARTICLE
Yu Luo, Bingyi Shi, Yeyong Qian, Hongwei Bai, Feng Liu
Allogeneic skin transplantation is an important clinical treatment for many diseases. Although Galectin-9 demonstrates multifaceted roles in modulating immune cell homeostasis and inflammation, its precise impact on balancing effector T cells and Tregs during allogeneic skin transplantation remains uncertain. This work was performed to evaluate the modulation of the survival time of allogeneic skin grafts by Gal-9 and to explore the critical mechanism involved in this process. Skin graft transplantation was conducted using C57BL/6 and BALB/c mice...
December 31, 2023: Cellular and Molecular Biology
https://read.qxmd.com/read/38274602/pancreatic-panniculitis-a-case-associated-with-acute-pancreatic-allograft-rejection
#39
Avraham Kohanzadeh, Ariel Sher, Olivia Wind, Qiang Liu, Pooja Srivastava, Bijal Amin, Ranon Mann
We present a unique case of pancreatic panniculitis (PP) in a 42-year-old male with a history of pancreas-after-kidney (PAK) transplant. The patient developed PP due to acute pancreas allograft rejection. Clinical manifestations included fevers, myalgias, arthralgias, and tender erythematous subcutaneous nodules on the lower extremities. A recent hospital admission was noted for acute pancreas allograft rejection related to low tacrolimus levels. Rheumatological and infectious disease workups were negative...
January 2024: Curēus
https://read.qxmd.com/read/38256691/heart-transplantation
#40
REVIEW
Nikolaos Chrysakis, Dimitrios E Magouliotis, Kyriakos Spiliopoulos, Thanos Athanasiou, Alexandros Briasoulis, Filippos Triposkiadis, John Skoularigis, Andrew Xanthopoulos
Heart transplantation (HTx) remains the last therapeutic resort for patients with advanced heart failure. The present work is a clinically focused review discussing current issues in heart transplantation. Several factors have been associated with the outcome of HTx, such as ABO and HLA compatibility, graft size, ischemic time, age, infections, and the cause of death, as well as imaging and laboratory tests. In 2018, UNOS changed the organ allocation policy for HTx. The aim of this change was to prioritize patients with a more severe clinical condition resulting in a reduction in mortality of people on the waiting list...
January 18, 2024: Journal of Clinical Medicine
keyword
keyword
121110
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.